Pillstats
Rx only · Tablet · Oral

Remibrutinib

Brands: Rhapsido · Remibrutinib

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCL04AA60
RxCUI (US)2724365
US makers1 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$20.82$41.65$62.47$83.29May 2026Jun 2026Jul 2026
$72.427
Latest avg · Jul 22, 2026
+1%
Since May 20, 2026
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2715418121.1K2025 Q42026 Q1
941
Rx · 2026 Q1
54K
Units dispensed
2
Quarters · since 2025 Q4

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Novartis Pharmaceuticals Corporationunknown3SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.